Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale"

Kos F. T., Yazici O., Civelek B., Seker M., ARIK Z., AKSOY S., ...Daha Fazla

WIENER KLINISCHE WOCHENSCHRIFT, cilt.126, sa.1-2, ss.36-41, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 126 Sayı: 1-2
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s00508-013-0453-9
  • Dergi Adı: WIENER KLINISCHE WOCHENSCHRIFT
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.36-41
  • Anahtar Kelimeler: Comorbidity, Charlson Comorbidity Index, Cumulative Illness Rating Scale, Pancreas, Cancer, PHASE-III TRIAL, CO-MORBIDITY, GEMCITABINE, CHEMOTHERAPY, AGE
  • Gazi Üniversitesi Adresli: Hayır

Özet

Effect of comorbidity on the treatments that patients receive is not clear, as healthy elderly patients and the elderly with less comorbid diseases are included in the studies. In the present study, the effect of comorbidity on the survival was evaluated using Charlson Comorbidity Index (CCI) and Cumulative Illness Rating Scale (CIRS).